FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
Stefan D. Anker, MD, PhD
Mahir Karakas, MD, PhD, MBA
Elevating Care for Patients With Severe Renal Disease in AAV
Silke R. Brix, MD, MRCP, SCPR
Andreas Kronbichler, MD
Implementing the SOC Induction Therapies in AAV
Bernhard Hellmich, MD
Optimizing AAV Outcomes: Maintenance Therapies
Managing Patients With AAV in the Rheumatology Clinic
Decoding ANCA-Associated Vasculitis (AAV): From Suspicion to Solution
Don't Miss It! Rapid & Accurate AAV Diagnosis
Tailoring Treatment for Optimal Outcomes in Patients With AAV
No Patient Left Behind! Advancing CKD-Associated Pruritus Care
Kieran McCafferty, MD
Maurizio Gallieni, MD
Breaking the Cycle: Addressing Hyperkalemia in CKD and Heart Failure to Optimize RAASi Therapy
Mikhail Kosiborod, MD
Stephen J. Greene, MD, FACC, FHFSA
Main Messages of New ESC Guidelines for CVD Management in Diabetes
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.